RBC Capital Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $66
Insider Sale: Director at $CGON (CGON) Sells 750 Shares
Express News | RBC Capital Reiterates Outperform on CG Oncology, Maintains $66 Price Target
A Quick Look at Today's Ratings for CG Oncology(CGON.US), With a Forecast Between $55 to $86
SUO-CTC and CG Oncology Announce the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
Analysts Offer Insights on NA Companies: Rubrik, Inc. Class A (RBRK) and CG Oncology, Inc. (CGON)
